We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

10 hedge funds and large institutions have $71.1K invested in Edesa Biotech in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

7.18% less ownership

Funds ownership: 7.53% → 0.35% (-7.2%)

17% less funds holding

Funds holding: 12 → 10 (-2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less capital inflows, than outflows

Capital inflows: $8.62K | Capital outflows: $1.75M

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WESPAC Advisors SoCal
WESPAC Advisors SoCal
California
+$4.31K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.85K
3
Creative Planning
Creative Planning
Kansas
+$616

Top Sellers

Rank Fund Capital Flow
1
Anson Funds Management
Anson Funds Management
Texas
-$1.71M
2
Advisor Group
Advisor Group
Arizona
-$27.7K
3
UBS Group
UBS Group
Switzerland
-$5.54K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$1K

EDSA Hedge Fund Activity: Q4 2016 in Review

10 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2016, worth a combined $71.1K — down 96% from $1.83M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EDSA positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was WESPAC Advisors SoCal, opening a new position worth an estimated $4.31K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.71M sold.

  • 10 institutional investors held Edesa Biotech (EDSA) as of Q4 2016, down from 12 in Q3 2016.
  • Funds reported $71.1K of Edesa Biotech stock for Q4 2016, down 96% quarter-over-quarter.
  • 3 funds opened new Edesa Biotech positions in Q4 2016 and 2 closed out, a net change of +1 holder.
  • The largest Edesa Biotech buyer in Q4 2016 was WESPAC Advisors SoCal, an estimated $4.31K added.
  • The largest Edesa Biotech seller in Q4 2016 was Anson Funds Management, an estimated $1.71M sold.

Based on aggregated 13F filings for Q4 2016.